Zhuang medicine composition assisted in resisting lung cancer

Abstract

The invention discloses a Zhuang medicine composition assisted in resisting lung cancer. The Zhuang medicine composition is characterized by being prepared from the following Zhuang medicinal materials: Nyarinngoux (Chinese name: baihuasheshecao), Gaeubwnhgauh (Chinese name: baiying), Byaekloekhauj (Chinese name: longkui), Buenqcilienz (Chinese name: banzhilian), Ginghgun (Chinese name: guangxi eshu), Fouxndoengz (Chinese name: shishangbai), Swnjgyaeujhenj (Chinese name: huanghuadaoshuilian), Raggongox (Chinese name: lugen), GO gyauhgujlanz (Chinese name: jiaogulan) and Lozhangoj (Chinese name: luohanguo). The Zhuang medicine composition is combined with chemical drugs for curing lung cancer, can reduce the toxic and side effects of inappetence caused by the chemical drugs, reduce the damage of the chemical drugs to immune organs, increase white blood cell count, blood platelet count, red blood cell count and hemoglobin count to reduce the inhibiting effect on myelosuppression, reduce the content of glutamic-pyruvic transaminase and glutamic oxalacetic transaminase to alleviate the damage to liver functions and increase the tumor suppression function of the chemical drugs. Namely, the Zhuang medicine composition is combined with the chemical drugs for curing the lung cancer and has the effects of toxicity reducing and efficacy enhancing.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a strong medicinal composition for auxiliary anti-lung cancer. Background technique [0002] Lung cancer, also known as primary bronchial lung cancer, refers to malignant tumors that mainly occur in the epithelial cells of the bronchial mucosa and a few occur in the alveolar tissue. The clinical incidence is extremely high, especially in recent years. Lung cancer has gradually become the first cause of death among urban residents in my country. As a malignant tumor, lung cancer is extremely harmful to human health. Due to the complex living environment that people face, and the biological characteristics of lung cancer are also very complicated. Only 15% of patients are diagnosed as local disease at the time of clinical diagnosis, and 25% of the disease is localized. Has disseminated to local lymph nodes, and more than 55% have distant metastasis, the overall 5-year ...

AI Technical Summary

Problems solved by technology

[0009] However, there are not many varieties that are actually accepted and used by doctors and patients. Except for Yifei Qinghua Granules, Xihuangjiedu Capsules and Pingxiao Tablets, a few varieties of Chinese patent medicines are widely recognized by doctors and patients. From the above patent documents, we can know that, At present, there is no specific Zhuang medicine variety for the treatment of lung cancer on the market

Images